Source - LSE Regulatory
RNS Number : 1369Y
PCGH ZDP PLC
11 May 2021
 

PCGH ZDP PLC

 

Legal Entity Identifier: 5493004C3YRF9HEVQI09

Half-Year Report and Financial Statements for the half year ended 31 March 2021

 

COMPANY INFORMATION

PCGH ZDP Plc (the 'Company') is a public limited company incorporated in England and Wales on 30 March 2017, with registration number 10700107. The principal legislation under which the Company operates is the Companies Act 2006. The Company's zero dividend preference (ZDP) shares have a standard listing on the London Stock Exchange.

 

 

  Enquiries:             Tracey Lago, ACIS

                                 Company Secretary

                                 Tel. 020 7227 2700

 

 

 

INTERIM MANAGEMENT REPORT

for the half year ended 31 March 2021

 

This interim management report is provided in accordance with the Disclosure Guidance and Transparency Rules (DTR) 4.2.7 and 4.2.8.

 

The Company is a public limited company with the sole purpose of issuing zero dividend preference (ZDP) shares and advancing the proceeds of the issue, by way of a loan, to the parent company. The Company is managed by a board of non-executive directors and the day to day operations are delegated to the Investment Manager, Polar Capital LLP. The Company's entire ordinary share capital is owned by the parent company while the ZDP shares have a standard listing on the London Stock Exchange. The parent company, Polar Capital Global Healthcare Trust Plc (PCGH) and the Company form the Group (the Group).

 

The sole objective of the Company is to repay the ZDP shareholders, on 19 June 2024, their entitlement to 122.99 pence per ZDP share. The performance of the Company in meeting this objective is directly linked to the performance of the parent company. To meet such objective, the parent company has provided an undertaking to the Company, whereby any shortfall between the final capital entitlement of 122.99 pence per ZDP share and the aggregate principal amount and interest due pursuant to the undertaking will be met in full by the parent company.

 

Directors

The Directors who served in office during the six months under review are as follows:

 

·      Lisa Arnold (Chair)

·      Neal Ransome

·      Andrew Fleming

·      Jeremy Whitley

 

All of the Directors are also serving directors of the parent company and therefore have an indirect interest in the loan and undertaking entered into by the Company and parent.

 

Principal Risks and Uncertainties

There have been no changes to the risks and uncertainties within the six months under review to those reported in the last annual report, and there were no events or otherwise during the period under review which had any significant effect on the Company, its objective or purpose. The Board continues to consider and monitor the risks and uncertainties relating to COVID-19 and the impact on the Company, its parent company and the performance of the parent company's underlying investments.

 

The board acknowledges its ultimate responsibility for managing the risks associated with the Company. The principal risks and uncertainties as identified by the Board are detailed below:

 

 

Capital Value:

The primary risk to the ZDP shareholders is that the assets of the Company are insufficient to repay the final capital entitlement of the ZDP Shares of 122.99 pence per share on the repayment date of 19 June 2024. The payment will be dependent on the parent company's ability to comply with its obligations under the loan and the undertaking.

 

Investment tenure:

There is a risk that there may not be a liquid secondary market for the ZDP shares. The investment should therefore be regarded as long-term in nature and should not be considered a suitable short-term investment.

 

 

Going Concern and Future Developments

In connection with new risks presented by the COVID-19 pandemic, the Board has undertaken additional financial analysis and engaged with the Investment Manager of the parent Company to review the results of such. Having carried out the additional testing, and continuation of the regular monitoring of the financial position of the Company and Group, the Board confirms that there continues to be a reasonable expectation that there are adequate resources to continue in operational existence for the foreseeable future. Accordingly, the Board continues to adopt the going concern basis in preparing the financial results of the Company. The Company does not have, and does not expect to have, any other business interests, and the current activities of the   Company are expected to continue until the scheduled ZDP Repayment Date of 19 June 2024 at which time  the Company will enter into voluntary liquidation.

 

 

Statement of Directors' Responsibilities

The Directors of PCGH ZDP Plc, who are listed on page 2, confirm to the best of their knowledge that:

•              The condensed set of financial statements has been prepared in accordance with IAS34 Interim Financial Reporting, in conformity with the requirements of the Companies Act 2006 and gives a true and fair view of the assets, liabilities, financial position and profit or loss of the Company for the six months ended 31 March 2021;

•              The Interim Management Report includes a fair review of the information required by the Disclosure Guidance and Transparency Rules 4.2.7R and 4.2.8R;

 

The half year financial report for the six-month period to 31 March 2021 has not been audited or reviewed by the Auditors. The half year financial report was approved by the Board on 11 May 2021.

 

Approved by the Board of Directors and signed on its behalf by:

 

 

 

Lisa Arnold

Chair

11 May 2021

 

 

 

 

STATEMENT OF COMPREHENSIVE INCOME

For the half year ended 31 March 2021

 

 

 

 

 

 

 

(Unaudited)

(Unaudited)

 (Audited)

 

 

Half year ended

Half year ended

Year ended

 

 

31 March 2021

31 March 2020

30 September 2020

 

 

 

Total

 

Total

Total

 

 

Return

Return

Return

 

Notes

£

£

£

 

 

 

 

 

Loan interest

2

431,300

421,937

850,478

Contribution from parent

3

93,872

89,339

181,519

 

 

 

 

 

 

 

 

 

 

Total income

 

525,172

511,276

1,031,997

 

 

 

 

 

 

 

 

 

 

Total expenses

 

-

 -

 -

 

 

 

 

 

Profit before finance costs and tax

525,172

511,276

1,031,997

 

 

 

 

 

Finance costs

 

 

 

 

 

 

 

 

 

Appropriation to ZDP shares

4

(525,172)

(511,276)

(1,031,997)

 

 

 

 

 

 

 

 

 

 

Total finance costs

 

(525,172)

(511,276)

(1,031,997)

 

 

 

 

 

Result before taxation

 

-

 -

 -

 

 

 

 

 

Taxation

 

-

 -

 -

 

 

 

 

 

Net result for the period and total comprehensive income

 

 

 

 

 

 -

 -

 -

 

The amounts dealt with in the Statement of Comprehensive Income are all derived from continuing activities.

 

The notes to follow form part of these financial statements.

 

 

 

STATEMENT OF CHANGES IN EQUITY

For the half year ended 31 March 2021

 

 

 

(Unaudited)

Half year ended 31 March 2021

 

 

Called up share capital

£

Capital reserve

£

Total equity

£

Total equity at 1 October 2020

50,000

-

50,000

-

-

-

Total equity at 31 March 2021

50,000

-

50,000

 

(Unaudited)

Half year ended 31 March 2020

 

 

Called up share capital

£

Capital reserve

£

Total equity

£

Total equity at 1 October 2019

50,000

-

50,000

-

-

-

Total equity at 31 March 2020

50,000

-

50,000

 

(Audited)

 Year ended

30 September 2020

 

 

Called up share capital

£

Capital reserve

£

Total equity

£

Total equity at 1 October 2019

50,000

-

50,000

-

-

-

Total equity at 30 September 2020

50,000

-

50,000

 

The notes to follow form part of these financial statements.

 

 

 

 

BALANCE SHEET

As at 31 March 2021

 

 

(Unaudited)

(Unaudited)

(Audited)

 

31 March 2021

31 March 2020

30 September 2020

 

£

£

£

 

 

 

 

Non-current assets

 

 

 

Loan to parent company

35,929,993

34,884,100

35,404,821

 

 

 

 

Current assets

 

 

 

Cash and cash equivalents

50,000

50,000

50,000

 

 

 

 

 

 

 

 

Total assets

35,979,993

34,934,100

35,454,821

 

 

 

 

Non-current liabilities

 

 

 

Zero dividend preference shares

(35,929,993)

(34,884,100)

(35,404,821)

 

 

 

 

 

 

 

 

Total liabilities

(35,929,993)

(34,884,100)

(35,404,821)

 

 

 

 

Net assets

50,000

50,000

50,000

 

 

 

 

Equity attributable to equity shareholders

 

 

 

Called up share capital

50,000

50,000

50,000

Capital reserve

-

-

-

 

 

 

 

 

 

 

 

Total equity

50,000

50,000

50,000

 

These financial statements of PCGH ZDP Plc were approved and authorised for issue by the Board of Directors on 11 May 2021. They were subsequently signed by:

 

 

Lisa Arnold

Chair

 

The notes to follow form part of these financial statements.

 

 

 

CASH FLOW STATEMENT

For the half year ended 31 March 2021

 

 

 

 

 

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Half Year Ended

Half Year Ended

 Year Ended

 

 

31 March 2021

31 March 2020

30 September 2020

 

 

£

£

£

 

 

 

 

 

Cash flows from operating activities

 

 

 

 

Profit before finance costs and taxation

 

525,172

511,276

1,031,997

 

 

 

 

 

Net cash inflow from operating activities

 

525,172

511,276

1,031,997

 

 

 

 

 

Cash flows from financing activities

 

 

 

 

 

 

 

 

 

Increase in payables

 

(525,172)

(511,276)

(1,031,997)

 

 

 

 

 

Net cash outflow from financing activities

 

(525,172)

(511,276)

(1,031,997)

 

 

 

 

 

Net increase in cash and cash equivalents

 

-

 -

-

 

 

 

 

 

Cash and cash equivalents at the beginning of the period

 

50,000

50,000

50,000

 

 

 

 

 

Cash and cash equivalents at the end of the period

 

50,000

50,000

50,000

 

  

The notes to follow form part of these financial statements.

 

 

NOTES TO THE FINANCIAL STATEMENTS

For the half year ended 31 March 2021

 

1.    General Information                                                                                                  

The Company's financial statements have been prepared under the historical cost convention modified to include the revaluation of certain investments. In line with the Company's parent, the financial statements have been prepared in accordance with International Financial Reporting Standards (IFRS), which comprise standards and interpretations approved by the International Accounting Standards Board (IASB) and International Accounting Standards Committee (IASC), in conformity with the requirements of the Companies Act 2006.

 

The financial information in this half year report does not constitute statutory accounts as defined in section 434 of the Companies Act 2006.                                                                                                     

                                                                                                                               

The financial information for the half year ended 31 March 2021 and 31 March 2020 has not been audited. The figures and financial information for the year ended 30 September 2020 are an extract from the latest published accounts and do not constitute statutory accounts for that period.

 

Full statutory accounts for the year ended 30 September 2020, prepared under IFRS, including the report of the auditors which was unqualified, did not draw attention to any matters by way of emphasis and did not contain a statement under section 498 of the Companies Act 2006, have been delivered to the Registrar of Companies.

 

The Company's accounting policies have not varied from those described in the financial statements for the year ended 30 September 2020.

                                                                                                                               

The Company's presentational currency is pounds sterling. Pounds sterling is also the functional currency of the Company because it is the currency of the primary economic environment in which the Company operates.

 

 

2.    Loan interest

Under a Loan Agreement the gross initial ZDP Placing proceeds have been lent to the Parent, Polar Capital Global Healthcare plc.  The loan agreement provides that interest will accrue on the loan at a daily rate of 2.5% compounded annually.

 

3.    Contribution from parent                                                                                                        

The contribution represents the additional funding required from the parent company to meet the entitlement due to the ZDP shareholders at the period end. The contribution from the parent as at 31 March 2021 was £93,872 (31 March 2020: £89,339 and 30 September 2020: £181,519).                                                                                           

 

4.    Finance costs                                                                                                               

The ZDP shares are designed to provide a pre-determined capital growth from their original issue price of 100p on 19 June 2017 to a final capital entitlement of 122.99p on 20 June 2024. The initial capital of 100p at 19 June 2017 will increase at an interest rate of 3% compounding annually. The provision for the capital growth entitlement on the ZDP shares is included as a finance cost.

                                                               

                                                                                               

5.    Net asset value per ZDP share               

 

 

 

 

 

 

 

 

(Unaudited)

(Unaudited)

(Audited)

 

 

Half Year Ended

Half Year Ended

 Year Ended

 

 

31 March 2021

31 March 2020

30 September 2020

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Calculated entitlement of ZDP shareholders (£)

 

35,929,993

34,884,100

35,404,821

 

 

 

 

 

ZDP shares in issue at the end of the year

 

32,128,437

32,128,437

32,128,437

Net asset value per ZDP share (pence)

 

111.83

108.58

110.20

 

 

 

 

 

                                                                               

               

6.    Related party                                                                                                      

The Company has provided an interest-bearing loan to its parent company, Polar Capital Global Healthcare Trust Plc. The loan is carried at amortised cost, which represents the initial cost of the loan plus accrued interest and any contribution due from the parent to meet the total ZDP entitlement. As at 31 March 2021, £35,929,993 was due from the parent company in respect of the loan (31 March 2020: £34,884,100 and 30 September 2020: £35,404,821).

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR GPUWAAUPGGAU
Find out how to deal online from £1.50 in a SIPP, ISA or Dealing account. AJ Bell logo

Related Charts

Polar Capital Global Healthcare Trust PLC (PCGH)

+5.68p (+1.47%)
delayed 09:48AM